Cytotoxic and Antibacterial Compounds from the Coral-Derived Fungus Aspergillus Tritici SP2-8-1
Overview
Pharmacology
Affiliations
Three novel compounds, 4-methyl-candidusin A (), aspetritone A () and aspetritone B (), were obtained from the culture of a coral-derived fungus SP2-8-1, together with fifteen known compounds (-). Their structures, including absolute configurations, were assigned based on NMR, MS, and time-dependent density functional theory (TD-DFT) ECD calculations. Compounds and exhibited better activities against methicillin-resistant strains of (MRSA) ATCC 43300 and MRSA CGMCC 1.12409 than the positive control chloramphenicol. Compound displayed stronger anti-MRSA and lower cytotoxic activities than , and showed stronger antibacterial activities against strains of , , and than the other compounds. Compounds and exhibited significantly stronger cytotoxic activities against human cancer cell lines HeLa, A549, and Hep G2 than the other compounds. Preliminary structure-activity relationship studies indicated that prenylation of terphenyllin or candidusin and the tetrahydrobenzene moiety in anthraquinone derivatives may influence their bioactivity.
Marine Fungi: A Prosperous Source of Novel Bioactive Natural Products.
Ji R, Zha X, Zhou S Curr Med Chem. 2023; 32(5):992-1006.
PMID: 37885109 DOI: 10.2174/0109298673266304231015070956.
Shah Z, Khan K, Rashid H, Shah T, Jaremko M, Iqbal Z BMC Microbiol. 2022; 22(1):295.
PMID: 36482311 PMC: 9733250. DOI: 10.1186/s12866-022-02693-w.
Anthraquinones and Their Analogues from Marine-Derived Fungi: Chemistry and Biological Activities.
Hafez Ghoran S, Taktaz F, Ayatollahi S, Kijjoa A Mar Drugs. 2022; 20(8).
PMID: 35892942 PMC: 9394430. DOI: 10.3390/md20080474.
Antibacterial Molecules from Marine Microorganisms against Aquatic Pathogens: A Concise Review.
Guo S, Zhang Z, Guo L Mar Drugs. 2022; 20(4).
PMID: 35447903 PMC: 9027299. DOI: 10.3390/md20040230.
Yu D, Qi S, Guan X, Yu W, Yu X, Cai M Front Pharmacol. 2022; 13:870367.
PMID: 35401187 PMC: 8993145. DOI: 10.3389/fphar.2022.870367.